nervous system
|
• at 12 months, mice exhibit demyelinating neuropathy unlike wild-type mice that is not as severe as in Mpztm1Msch heterozygotes or Ccl2tm1Rol/Ccl2+ Mpztm1Msch/Mpz+ mice
|
|
• at 12 months but not as severe as in Mpztm1Msch heterozygotes or Ccl2tm1Rol/Ccl2+ Mpztm1Msch/Mpz+ mice
|
immune system
|
• at 12 months, the number of foam macrophages in the quadriceps nerve is decreased compared to in Ccl2tm1Rol/Ccl2tm1Rol Mpztm1Msch/Mpz+ mice
|
|
• at 6 months, the number of macrophages in the quadriceps nerves is decreased compared to in Mpztm1Msch heterozygotes
• at 12 months, the number of macrophages in the quadriceps nerve is decreased compared to in Mpztm1Msch heterozygotes and Ccl2tm1Rol/Ccl2tm1Rol Mpztm1Msch/Mpz+ mice
|
hematopoietic system
|
• at 12 months, the number of foam macrophages in the quadriceps nerve is decreased compared to in Ccl2tm1Rol/Ccl2tm1Rol Mpztm1Msch/Mpz+ mice
|
|
• at 6 months, the number of macrophages in the quadriceps nerves is decreased compared to in Mpztm1Msch heterozygotes
• at 12 months, the number of macrophages in the quadriceps nerve is decreased compared to in Mpztm1Msch heterozygotes and Ccl2tm1Rol/Ccl2tm1Rol Mpztm1Msch/Mpz+ mice
|
cellular
|
• at 12 months, the number of foam macrophages in the quadriceps nerve is decreased compared to in Ccl2tm1Rol/Ccl2tm1Rol Mpztm1Msch/Mpz+ mice
|


Analysis Tools